Lauren Santye, Assistant Editor

Top HCV articles of the year on Specialty Pharmacy Times.

Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses effective measures for maintaining adherence to specialty drug regimens.

Top HIV articles of the year on Specialty Pharmacy Times.

HIV hiding in the brain can cause damage to the patient.

Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at UIC College of Pharmacy, discusses the challenges patients face when starting a specialty medication regimen.

Patients share their personal stories with Specialty Pharmacy Times.

Jardiance reducea the risk of cardiovascular death in adults with type 2 diabetes mellitus and cardiovascular disease.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses challenges in gaining access to cholesterol-lowering PCSK9 inhibitors.

Proton pump inhibitors combined with a certain chemotherapy drug may lower the possibility for cancer patients to recover and survive.

Emicizumab prophylaxis reduced the number of bleeds in hemophilia A patients.

Emicizumab prophylaxis decreases bleeding episodes in hemophilia A patients.

Top news of the day from across the health care landscape.

Scientists have developed a new tool to test current strategies for finding mutant gene cancer drivers.

Regular use of over-the-counter, anti-inflammatory drugs associated with an increased risk of death in patients with cancer.

Regular use of over-the-counter, anti-inflammatory drugs associated with an increased risk of death in patients with cancer.

Undisclosed academic and financial conflicts of interest may influence analysis of clinical research.

Investigative drug may improve overall survival and reduce chemotherapy-induced heart damage in children with acute myelogenous leukemia.

Cisplatin used in combination with sodium thiosulfate significantly reduced the incidence of hearing loss in pediatric cancer patients.

Study finds link between aspirin and blood platelets in cancer cells.

Top news of the day from across the health care landscape.

Metastasis affects as many as 5% of cancer patients around the world.

Top news of the day from across the health care landscape.

After 2 years of exclusion, Harvoni has been added to the Express Scripts national formulary for the treatment of hepatitis C.

Cyclin-dependent kinase inhibitor reduces Ki67 expression and shows promise in breast cancer treatment.

Agreement will expand treatment options for patients with hepatitis C.

HIV infection continues to rise in across European countries.

Top news of the day from across the health care landscape.

Pembrolizumab was associated with clinically meaningful improvements in quality of life over chemotherapy.

Anti-inflammatory drugs suppress PGE2 production and leads to adverse events from peripheral blood hematopoietic stem cell harvesting.

Top news of the day from across the health care landscape.